HEALTHJul 27 · 13:20 UTCQUARTZCris Tolomia

Doctors and the FDA are raising alarms over compounded weight loss drugs

The FDA issued 25 warning letters to telehealth companies over misleading claims about compounded versions of drugs like Ozempic. Doctors and the FDA are raising concerns about these compounded weight loss drugs.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned

FDAorganizationTelehealth companiesorganizationcompounded weight loss drugstopicOzempictopic

Spot something wrong with this article?Report a problem →

Forward this

Related Signal

Adjacent reporting

HEALTHJun 12 · 17:01 UTC
The FDA Issued a Warning on Which Weight-Loss Drug?
HEALTHJun 8 · 12:16 UTC
Doctors prescribing weight loss drug not yet approved by FDA, CBS News investigation finds
HEALTHJun 27 · 15:19 UTC
Doctors' fears over long-term Ozempic use: DR SHEILA sounds the alarm over GLP-1 weight-loss drugs for young patients
HEALTHJun 9 · 00:54 UTC
Safety concerns over doctors prescribing experimental weight loss drug not approved by FDA
HEALTHJul 27 · 11:14 UTC
Compounded GLP-1 drugs creating concern among doctors and FDA